
期刊简介
《国际眼科杂志·IJO》简介 《国际眼科杂志》(International Journal of Ophthalmology)是在世界卫生组织和国际眼科理事会的指导和支持下,由中华医学会西安分会主办的国际性中英文混合版眼科专业学术期刊。中国标准连续出版物号ISSN1672-5123、CN61-1419/R。本刊于2000年创刊,现为月刊。《国际眼科》杂志社是经国家工商总局审名注册的独立法人机构,胡秀文总编为法人代表。本刊由国际眼科理事会主席G.O.H. Naumann/Bruce E. Spivey教授和世界卫生组织特别顾问R. Pararajasegaram教授及国际防盲协会主席G.N.Rao教授出任总顾问;中华眼科学会原主任委员张士元教授等出任名誉总编;陕西省眼科学会常委胡秀文教授任社长/总编辑;第四军医大学全军眼科研究所所长惠延年教授任主编;中华眼科学会主任委员黎晓新教授及陕西省眼科学会主任委员王雨生教授等任副主编。本刊已被荷兰《医学文摘》、美国《化学文摘》、俄罗斯《文摘杂志》和国家科技部中国科技论文统计源(中国科技核心期刊)等国内外权威性检索系统收录,并被评为陕西省优秀科技期刊。据权威机构统计,2006年本刊影响因子为1.063,在我国16种眼科专业期刊中名列第二。它是我国眼科领域唯一的国际性刊物,遵照“让中国眼科走向世界 让世界眼科关注中国”的办刊宗旨,现已率先实现编委会及稿源国际化。英文原著栏目为本刊特色栏目,所刊发的全英文论文和国际论文居国内眼科杂志之首。它已成为我国眼科界对外交流的一个重要窗口,并已成为海内外知名的国际性眼科专业学术期刊。本刊为一综合性眼科专业学术期刊,涵盖面广、信息量大;包括眼科基础研究和临床研究及相关学科研究论文。我们本着“想读者之所想、急作者之所急”的办刊理念,将竭诚为广大作者读者服务。欢迎投稿、欢迎订阅、欢迎引用本刊文献!地址:(710054)中国西安友谊东路269号电话:029-82245172/83085628 传真:029-82245172邮箱:ijo.2000@163.com ijo2000@126.com网址:www.IJO.cn;www.world-eye.cn(国际眼科网)
SCI论文投稿全程模板实例
时间:2024-03-22 09:31:25
SCI论文投稿全程模板主要包括以下几个部分:投稿信(Cover Letter)、论文正文、作者信息和致谢等。下面将详细介绍这些部分,并给出实例说明。
一、投稿信(Cover Letter)
投稿信是向编辑介绍论文内容和作者情况的重要文件,也是论文投稿过程中必不可少的一部分。在投稿信中,作者需要简要介绍论文的研究背景、目的、方法、结果和结论,同时说明论文的创新性和重要性。此外,作者还需要提供自己的联系方式和作者简介等信息。
以下是一个投稿信的实例:
Dear Editor,
We are pleased to submit our manuscript entitled "XXX" for consideration for publication in your journal. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
We believe that our study is of great interest to the readers of your journal and will contribute significantly to the field of XXX research. We have carefully checked the manuscript for typographical and grammatical errors, and have ensured that the data presented are accurate and reproducible.
Please find attached the manuscript files in Word and PDF formats, as well as the figures and tables in separate files. We have also included a list of potential reviewers for your consideration. However, we would like to note that we have no conflicts of interest with any of the reviewers listed.
Thank you for considering our manuscript for publication in your journal. We look forward to hearing from you soon.
Sincerely,
[Your Name]
[Your Affiliation]
[Your Email Address]
二、论文正文
论文正文是SCI论文投稿的核心部分,包括标题、摘要、关键词、引言、方法、结果、讨论和结论等部分。在撰写论文正文时,作者需要遵循学术规范和论文写作要求,确保论文内容准确、清晰、有条理。
以下是一个论文正文的实例(仅包含部分部分):
Title: The effect of XXX on XXX in a mouse model of XXX
Abstract: In this study, we investigated the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
Keywords: XXX; XXX; Mouse model; Therapeutic agent
Introduction: XXX is a common disease that affects millions of people worldwide. Current treatments for XXX are limited and often associated with side effects. Therefore, there is an urgent need to develop new therapeutic agents for the treatment of XXX. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX.
Methods: We used a mouse model of XXX to investigate the effect of XXX on XXX. Mice were randomly divided into two groups: a control group and a treatment group. The treatment group received XXX at a dose of XXX mg/kg/day for XXX days. All mice were sacrificed at the end of the experiment, and the levels of XXX were measured using XXX assay.
Results: We found that the levels of XXX were significantly reduced in the treatment group compared to the control group (Figure 1). In addition, the symptoms of XXX were also improved in the treatment group (Table 1).
Discussion: Our findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX. The reduction in the levels of XXX and improvement in the symptoms of XXX observed in our study are consistent with previous reports suggesting that XXX has anti-inflammatory and antioxidant properties. However, further studies are needed to confirm the efficacy and safety of XXX in humans.
Conclusion: In conclusion, we found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in a mouse model of XXX. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX and warrant further investigation in clinical trials.
(注:以上实例中的XXX需要根据实际情况进行替换。)
三、作者信息和致谢
在论文正文的最后,作者需要提供详细的作者信息和致谢。作者信息包括作者的姓名、单位、联系方式等;致谢则是对在论文撰写过程中给予帮助和支持的人或机构表示感谢。
以下是一个作者信息和致谢的实例:
Authors: [Your Name], [Co-author's Name], [Another Co-author's Name]
Affiliations: [Your Affiliation], [Co-author's Affiliation], [Another Co-author's Affiliation]
Contact Information: [Your Email Address], [Your Phone Number]
Acknowledgments: We would like to thank [Name of Funding Agency] for providing financial support for this study. We also thank [Name of Individual] for their assistance with data collection and analysis. Finally, we would like to express our gratitude to the anonymous reviewers for their valuable comments and suggestions on the manuscript.